6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
22m ago	E-Power Subsidiary Awarded Key Patent for Advanced Silicon-Carbon Composite Materials, Strengthening Solid-State Battery Innovation
48m ago	DRIVERS AT FLOWERS FOODS RATIFY FIRST CONTRACT
48m ago	Sallie Mae Expands Access to Responsible Financing For Students Pursuing Graduate and Law Degrees
48m ago	Magnera Announces Participation at the Barclays 30th Annual Leveraged Finance Conference
48m ago	Leading U.S. Health & Benefits Advocacy Group Honors HII with 2026 Best Employers Award for Excellence in Health Care Value

About

Duality Biotherapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

DualityBio (9606.HK) Announces 2025 Annual Results

DualityBio's Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting

FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

Recent Videos

Duality Biotherapeutics Inc. 2025 annual report

Duality Biotherapeutics Inc. 2025 annual report

Apr 27, 2026

Dualitybio-B 2025 interim report

Dualitybio-B 2025 interim report

Sep 18, 2025

Community Chat

Ask AI